Treatment strategies for neuromyelitis optica

@inproceedings{Huang2018TreatmentSF,
  title={Treatment strategies for neuromyelitis optica},
  author={Tzu-Lun Huang and Kung-Hung Lin and Jia-kang Wang and Rong Kung Tsai},
  booktitle={Ci ji yi xue za zhi = Tzu-chi medical journal},
  year={2018}
}
Neuromyelitis optica (NMO) is an autoimmune demyelinating disease with pathogenic autoantibodies that act against the astrocyte water channel protein, i.e. aquaporin-4: the disease is associated with recurrent episodes of optic neuritis (ON) and transverse myelitis, often resulting in severe disability. The main goals in treatment of NMO include acute symptomatic therapy and long-term stabilization of symptoms by preventing relapse. In recent years, ongoing randomized controlled trials in NMO… CONTINUE READING

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 53 REFERENCES

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica

N Collongues, J deSeze
  • Ther Adv Neurol Disord
  • 2016